Anaplastic Astrocytoma — Trials

Anaplastic Astrocytoma — Trials · CancerIndex

Clinical trials

Registered studies

209 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 22
Ph III recruiting: 2
Growth YoY: —
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (45)

clinicaltrialsPublishedShowing 201–209 of 209 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00089427	IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma	completed	Phase 1	24	INSYS Therapeutics IncINDUSTRY	1	Jul 4, 2011	clinicaltrials
NCT00024557	Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients	completed	Phase 1	40	INSYS Therapeutics IncINDUSTRY	1	Jun 6, 2011	clinicaltrials